Maker of Stopain extends Arthritis Foundation sponsorship
DRJ Group Inc., the maker of Stopain all-natural topical analgesics, is continuing its support of the Arthritis Foundation by renewing its proceeds sponsorship.
CDR
Standley takes helm as new Rite Aid CEO
Before the end of the day, Rite Aid Corp. will get a new chief executive officer: John Standley. Standley, 47, is set to become Rite Aid president and CEO after the company’s annual shareholder meeting Wednesday in Camp Hill, Pa. He will take the chief executive reins from Mary Sammons, 63,
Rite Aid posts smaller loss in 1Q
Rite Aid Corp. saw sales dip in its fiscal 2011 first quarter but recorded a smaller year-over-year loss and topped Wall Street’s earnings forecast. The drug store chain on Wednesday said its net loss for the 13-week first quarter ended May 29 was $73.7 million, or 9 cents per diluted share,
Hallmark unveils ‘Girlfriends’ card collection
Hallmark Cards has launched the Girlfriends collection, a line of greeting cards and gifts designed to help women connect in a fun, humorous and meaningful way.
Takeda ships ACTOplus met XR tablets for diabetes
Takeda Pharmaceuticals North America Inc. said ACTOplus met XR tablets, an extended-release version of the diabetes combination medication ACTOplus met (pioglitazone HCl and metformin HCl), are now available in U.S. pharmacies.
Valeant, Biovail plan to merge
Specialty pharmaceutical makers Valeant and Biovail have agreed to merge, with the combined company to be called Valeant Pharmaceuticals International Inc.
GPhA names interim executive team
The Generic Pharmaceutical Association (GPhA) has formed an interim executive team to lead the organization until it appoints a new chief executive officer to replace Kathleen Jaeger, who is due to step down from the post later this month.
Walmart, Lilly partner to provide ‘affordable’ insulin
Walmart and drug maker Eli Lilly & Co. are teaming up to provide what they call an "affordable insulin option" for people with diabetes.
Walgreens sees drop in 3Q earnings
Despite an uptick in sales, Walgreen Co. saw its fiscal 2010 third-quarter earnings drop due in part to special charges and the loss of a key tax benefit. The drug store chain said Tuesday that net earnings for the quarter ended May 31 totaled $463 million, or 47 cents per diluted share,
Kowa Pharmaceuticals, Lilly launch Livalo
Kowa Pharmaceuticals America Inc. and Eli Lilly and Co. have rolled out cholesterol-lowering drug Livalo to retail pharmacies in the United States. The drug makers said Monday that Livalo (pitavastatin) is available in 1 mg, 2 mg and 4 mg tablets.
NCPA backs call for GAO study of Medicaid cost of dispensing
A proposal for a study of the factors that influence a pharmacy’s cost of dispensing a Medicaid prescription may be included in an amendment to legislation pending before the Senate, the National Community Pharmacists Association reported.
Kinney promotes financial exec, hires retail director
Kinney Drugs has promoted Michael Burgess to vice president of financial planning and treasury services and hired Duckwall-ALCO executive Jim Spencer as director of retail operations.
Health Mart honors merchandising partner SPAR Group
Health Mart has named retail merchandising and marketing services provider SPAR Group Inc. as its Consumer Products Group Partner of the Year. Tarrytown, N.Y.-based SPAR Group said Friday it’s the inaugural recipient of the award from the drug store franchise, which is a subsidiary of McKesson Corp.
Mylan gets FDA OK for generic Zocor
Mylan Inc.’s Matrix Laboratories Ltd. subsidiary has received final approval from the Food and Drug Administration for simvastatin tablets, which treat high cholesterol.
Kimberly-Clark makes executive moves
Kimberly-Clark Corp. has made executive changes that it said will sharpen its focus on continuous improvement, global sourcing and sustainability. The company also elected a new board member.
FDA issues alert on fraudulent Tamiflu
The Food and Drug Administration is warning consumers about a potentially harmful product represented as "Generic Tamiflu" that’s sold on the Internet. There’s no FDA-approved generic drug for the prescription product Tamiflu, the agency reported Thursday.